HEALTH SECURITY

Ms. Torres
 HEALTH
SECURITY

DENGVAXIA

hpttp://www.google.com/search?q=Dengvaxia

Dengue vaccine is a human vaccine that

prevents dengue disease.
The Philippines is experiencing a statewide epidemic of dengue fever,
a mosquito-borne tropical disease that causes flu-like symptoms and
can be fatal, especially in youngsters.
 HEALTH
SECURITY
BACKGROUND

APRIL, 2016 NOVEMBER, 2017

Dengvaxia had a high-profile After at least one dose of

introduction in the Philippines in the the vaccine had been
year 2016. After participating the given to over 830,000
country became the first in the world children, was more than six
to obtain the live recombinant months later. Sanofi
tetravalent vaccine. The Department declared that its label
of Health invested $67 million on would be changed to allow
Dengvaxia as they began a mass only people who have
vaccination campaign with the goal previously been
of immunizing one million unprotected from the said
schoolchildren by vaccinating them. virus to use it.
 HEALTH
SECURITY

BACKGROUND

FEBRUARY, 2018 DECEMBER, 2018

Within a few months, it was Sanofi pursued

stated that 160 children had regulatory permission for
died due to and the vaccine Dengvaxia to those
drive's possible consequences children who already
had become a national issue, experience being
with critizism being directed at hospitalized because of
both pharmaceutical dengue and in
companies and healthcare December 2018, the
executive. company received it.
 HEALTH
SECURITY

BACKGROUND

PAGE 5

Vaccine Hesitancy

has been built upon due to the

controversy of Dengvaxia that killed
several children.

 Philippines Dengvaxia International Dengvaxia

Program Program

The rollout of Dengvaxia has been widespread

Singapore's national immunization program
up to those children who do not suffer from
does not include dengue vaccination. People
the dengue also get vaccinated.
are only given the vaccine if the benefits

outweigh the hazards.

There is no clear instruction on who is getting
the Dengvaxia.

In the city-state, there are protections in place,
Though it was stated that the dengue vaccine testing to determine if a person has a dengue
has could pose for a high-risk illness called infection
seronegative patients
Dengvaxia's Roll-out Program gap in
the Philippines

The vaccine for dengue was approved by the Philippines though there are
some possible risks that a child might have still accepted by the DOH

There is a lack of information that the DOH had stated made the Filipino
citizen miss interpret the vaccine roll-out.
 References:
Fatima, K. & Syed, N. I. (2018). Dengvaxia controversy: impact on vaccine hesitancy
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214489/

Lo, C. (2019). The dengue vaccine dilemma

https://www.pharmaceutical-technology.com/features/dangvaxia-philippines/

Philippines Daily Inquirer (2019). IN THE KNOW: Dengvaxia vaccine in other countries
https://newsinfo.inquirer.net/1161038/in-the-know-dengvaxia-vaccine-in-other-
countries